Telehealth, Interoperability Major Hurdles For Decentralized Clinical Trials

The COVID-19 public health emergency increased the use of decentralized clinical trials, including through telehealth and remote monitoring, but clinical trial experts say a plethora of pre-pandemic barriers remain that hurt the viability of the modality. Telehealth advocates tout the promise of decentralized clinical trials to make or break new medical treatments faster and increase the diversity of participants. However, post-pandemic, the remote clinical trial regulatory landscape is as complicated as ever, experts say. Congress and the administration have expressed...